Source: Eur Respir J 2003; 22: 72S-76S
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Girou E.. Prevention of nosocomial infections in acute respiratory failure patients. Eur Respir J 2003; 22: 72S-76S

Member's Comments

No comment yet.

Related content which might interest you: Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome Source: Eur Respir J 2002; 20: 1483-1489 Year: 2002 Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia Source: Annual Congress 2007 - Infections year in review Year: 2007 Lower respiratory tract infections: when are antibiotics mandatory? Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146 Year: 2004 Late-onset ventilator-associated pneumonia in patients with acute nervous system infections Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track Year: 2005 Fluoroquinolones and lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=94 Year: 2004 Impact of appropriate diagnostics on the management of respiratory tract infections Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021 Year: 2021 Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients Source: Eur Respir J 2003; 22: 77S-83S Year: 2003 Antibiotics and new guidelines for the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=175 Year: 2004 Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia Source: ERS Course 2018 - Respiratory Infections Year: 2018 Prevention of ventilator-associated pneumonia: possible role of antimicrobials administered via the respiratory tract Source: Eur Respir J 2008; 31: 1138-1139 Year: 2008 NIV in community-acquired pneumonia Source: Annual Congress 2005 - Noninvasive ventilation (NIV) in hypoxaemic acute respiratory failure (ARF) Year: 2005 MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia Source: Eur Respir J 2009; 34: 1470-1476 Year: 2009 VAP prevention: pharmacological strategies Source: Eur Respir Mon 2011; 53: 74-82 Year: 2011 Epidemiology of community-acquired pneumonia and nosocomial pneumonia Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis Source: Eur Respir J 2011; 37: 858-864 Year: 2011 Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009 Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens Source: Eur Respir J 2002; 20: 432-439 Year: 2002 The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010